Company: PHR
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001412408-25-000039
Chunk: 75

Company: Phreesia, Inc.
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 1
Chunk 75
---
1,364)Net cash used in financing activities(838)(1,825)Effect of exchange rate changes on cash and cash equivalents31 (1)Net increase (decrease) in cash and cash equivalents6,651 (7,993)Cash and cash equivalents – beginning of period84,220 87,520 Cash and cash equivalents – end of period$90,871 $79,527 

11

Table of Contents

Supplemental information of non-cash investing and financing information:Right of use assets acquired in exchange for operating lease liabilities$— $764 Property and equipment acquisitions through finance leases$— $6,529 Purchase of property and equipment and capitalized software included in current liabilities$1,117 $2,440 Capitalized stock-based compensation$332 $348 Issuance of stock to settle liabilities for stock-based compensation$6,508 $6,177 Cash paid for:Interest$324 $483 Income taxes$551 $1,593 

See notes to unaudited consolidated financial statements

12

Table of Contents

Phreesia, Inc.

Notes to Unaudited Consolidated Financial Statements

(in thousands, except share and per share data)

1. Background and liquidity

(a) BackgroundPhreesia, Inc. (the "Company") is a leading provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations and improve health outcomes by helping patients take a more active role in their care. The Company has created an integrated and streamlined system that automates data capture and activates patients before, during and after their interaction with their healthcare services provider. The Company's solutions include SaaS-based integrated tools that manage patient access, registration and payments. Additionally, the Company offers tools to communicate with patients about their health that have demonstrated increased rates of preventive care and vaccinations. Additionally, Phreesia's solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to better understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations with a channel for direct education and communication with patients in a privacy-protected environment. Phreesia's solutions also include additional products and services such as the MediFind provider directory, which helps patients find care based on providers' specialty and condition expertise. Phreesia offers its healthcare services clients the